Literature DB >> 16416658

Expression of stretch-activated potassium channels in human myometrium.

Jennifer N Tichenor1, Eric T Hansen, Iain L O Buxton.   

Abstract

Using RT-PCR and a semiquantitative method to detect relative differences in mRNA expression, we examined uterine smooth muscle from both pregnant and non-pregnant women for the expression of members of weak inwardly rectifying 2-pore potassium channel family (TWIK), TREK and TRAAK. We show for the first time that TRAAK transcript is present in uterine smooth muscle, albeit at relatively low levels. The expression of TREK is far more robust. Trek-1 but not TREK-2 was expressed in both pregnant and non-pregnant myometrium. Comparison of TREK-1 expression in several hysterectomy samples relative to 18S ribosomal mRNA suggested that expression may be regulated or could vary from subject to subject since expression was not see in some women. A similar result was obtained in pregnant samples. When all samples expressing TREK-1 were compared, a significant increase in TREK-1 expression was seen in pregnant term tissues from women not in labor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416658

Source DB:  PubMed          Journal:  Proc West Pharmacol Soc        ISSN: 0083-8969


  11 in total

1.  TREK-1 currents in smooth muscle cells from pregnant human myometrium.

Authors:  Nathanael S Heyman; Chad L Cowles; Scott D Barnett; Yi-Ying Wu; Charles Cullison; Cherie A Singer; Normand Leblanc; Iain L O Buxton
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-26       Impact factor: 4.249

2.  The stretch-dependent potassium channel TREK-1 and its function in murine myometrium.

Authors:  Kevin Monaghan; Salah A Baker; Laura Dwyer; William C Hatton; Kyung Sik Park; Kenton M Sanders; Sang Don Koh
Journal:  J Physiol       Date:  2011-01-10       Impact factor: 5.182

3.  Variants of stretch-activated two-pore potassium channel TREK-1 associated with preterm labor in humans.

Authors:  Yi-Ying Wu; Cherie A Singer; Iain L O Buxton
Journal:  Biol Reprod       Date:  2012-10-25       Impact factor: 4.285

4.  Adaptive reduction of human myometrium contractile activity in response to prolonged uterine stretch during term and twin pregnancy. Role of TREK-1 channel.

Authors:  Zongzhi Yin; Wenzhu He; Yun Li; Dan Li; Hongyan Li; Yuanyuan Yang; Zhaolian Wei; Bing Shen; Xi Wang; Yunxia Cao; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-03-22       Impact factor: 5.858

Review 5.  A role of stretch-activated potassium currents in the regulation of uterine smooth muscle contraction.

Authors:  Iain L O Buxton; Nathanael Heyman; Yi-ying Wu; Scott Barnett; Craig Ulrich
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 6.  Molecular regulations governing TREK and TRAAK channel functions.

Authors:  Jacques Noël; Guillaume Sandoz; Florian Lesage
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

7.  Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.

Authors:  Qi Lei; Xiao-Qing Pan; Shaohua Chang; S Bruce Malkowicz; Thomas J Guzzo; Anna P Malykhina
Journal:  J Physiol       Date:  2014-05-06       Impact factor: 5.182

8.  Expression of stretch-activated two-pore potassium channels in human myometrium in pregnancy and labor.

Authors:  Iain L O Buxton; Cherie A Singer; Jennifer N Tichenor
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Alternatively Spliced Human TREK-1 Variants Alter TREK-1 Channel Function and Localization.

Authors:  Chad L Cowles; Yi-Ying Wu; Scott D Barnett; Michael T Lee; Heather R Burkin; Iain L O Buxton
Journal:  Biol Reprod       Date:  2015-09-23       Impact factor: 4.285

10.  A comparison of the contractile properties of myometrium from singleton and twin pregnancies.

Authors:  Peter Turton; Sarah Arrowsmith; Jonathan Prescott; Celia Ballard; Leanne Bricker; James Neilson; Susan Wray
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.